We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

Blogs for October 2010

CD Antibodies Uncover Markers for Rare Breast Cancer

Friday, October 29, 2010 - 07:11

We at Novus Biologicals have added several new products to our CD antibody database. The CD, or Cluster of Differential proteins are a family of type I transmembrane glycoproteins widely expressed in immune cell populations. These include B cells, thymocytes and peripheral T cells. Widely used as cell markers, a recent antibody study identified three CD proteins - CD44+, CD49fhi, and CD133hi – as new cell markers in an aggressive, but uncommon type of breast cancer.

The CD system was originally defined in 1982, at the First International Workshop and Conference on Human Leukocyte Differentiation Antigens (HDLAs). It was known that various research teams had succeeded in generating a large number of monoclonal antibodies targeting surface epitopes on white blood cells. The aim of the conference was to standardize the system, which was extended to include other cells...

The Heat is On: Heat Shock Proteins and the Link to Cancer

Monday, October 25, 2010 - 07:09

Novus Biologicals offers an extensive antibody catalog targeting heat shock proteins (HSPs). A large protein group covering a number of families, the HSPs are functionally related by their dramatic upregulation in response to stress. Stress triggers may include a rise in temperature or a similar environmental cause. Transcription is controlled by the heat shock factor, or HSF, protein family.

The heat shock proteins are found in all living organisms including bacteria and yeasts. They are of particular interest to oncology researchers as they are implicated in a number of cancers, in particular breast cancer – one of the biggest killers of women in the UK. The heat shock molecules on our antibody database are identified by the prefix HSP, followed by their molecular weight, which can range from 27 to over 140 kilodaltons in size. The three most widely studied proteins are...

Industrial Chemicals, Tumour Suppressor Genes and the Need for More Research

Wednesday, October 20, 2010 - 07:07

Human cancer research is the largest research area in our antibody database, with new oncogenes and cell lines being added all the time.

Cancer triggers come from many sources, with a worrying amount of evidence to suggest that chemicals we’re in contact with every day are largely to blame. Over 100,000 products exist today for which there is little, if any, safety data. Screening for carcinogens was unknown before the 1980s. So far, just 3000 of these chemicals have undergone screening – over 800 were mutagens or carcinogens. Obviously, much more research needs to be done!

Researchers tackle cancer from both angles; cause and prevention. Tumor suppressor antibody studies are an important part of this. Tumor suppressors are genes that reduce the likelihood of a cell becoming cancerous, by blocking the action or production of other proteins, such as growth factors and...

It's a Wiz: Merlin Antibodies Advance Hepatic Tumor Research

Friday, October 15, 2010 - 07:03

The NF2 gene, also known as “Merlin”, was discovered through studies into Neurofibromatosis Type II, a rare genetic disease which causes formation of non-malignant, but life-limiting, brain tumors. NF2 encodes a cytoskeletal protein involved in extracellular signalling (i.e. cell-to-cell). It is also known to act as a tumor suppressor to several membrane-bound growth factors, including the oncogene EGFR. We at Novus Biologicals have a large selection of antibodies and lysates in our catalog for Merlin studies.

Antibodystudies into EGFR have shown overproduction leads to several cancers, including hepatic cancer. A new study set out to look at the role NF2 plays in preventing formation of these...

The Magic of Merlin: Antibodies Point to New Role in Liver Cancer

Monday, October 11, 2010 - 06:59

The Merlin protein belongs to the ezrin/radixin/moesin (ERM) family of tumour suppressor proteins. Encoded by the rather less imaginatively named Neurofibromin 2 (NF2) gene, it is thought to play a role in extracellular signal transduction, linking the cell cytoskeleton with membrane-bound proteins and suppressing several receptors, including the epidermal growth factor receptor (EGFR). The Merlin antibodies in our antibody catalog are widely used in cancer studies, since overexpression of EGFR is known to cause several cancers.

NF2 itself can act as an oncogene - first discovered through its connection with neurofibromatosis 2, a rare genetic disorder. NF2 mutations can also cause neuronal tumors. Recently, a study led by a team of researchers from Massachusetts General Hospital revealed...


Blog Topics


Archives